129 related articles for article (PubMed ID: 1688704)
21. Clorgyline and desipramine alter the sensitivity of [3H]noradrenaline release to calcium but not to clonidine.
Campbell IC; McKernan RM
Brain Res; 1986 May; 372(2):253-9. PubMed ID: 3011209
[TBL] [Abstract][Full Text] [Related]
22. Characterization of 125I-lysergic acid diethylamide binding to serotonin receptors in rat frontal cortex.
Kadan MJ; Krohn AM; Evans MJ; Waltz RL; Hartig PR
J Neurochem; 1984 Sep; 43(3):601-6. PubMed ID: 6747625
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists-LY53857, sergolexole, and LY237733.
McBride PA; Mann JJ; Nimchinsky E; Cohen ML
Life Sci; 1990; 47(23):2089-95. PubMed ID: 2125095
[TBL] [Abstract][Full Text] [Related]
24. Electrophysiological and receptor studies in rat brain: effects of clorgyline.
Campbell IC; Gallager DW; Hamburg MA; Tallman JF; Murphy DL
Eur J Pharmacol; 1985 May; 111(3):355-64. PubMed ID: 2990957
[TBL] [Abstract][Full Text] [Related]
25. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
Nash JF; Arora RC; Schreiber MA; Meltzer HY
Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
[TBL] [Abstract][Full Text] [Related]
26. Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers.
Spigset O; Mjörndal T
Psychopharmacology (Berl); 1997 Sep; 133(1):39-42. PubMed ID: 9335078
[TBL] [Abstract][Full Text] [Related]
27. 2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors.
Engel G; Müller-Schweinitzer E; Palacios JM
Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):328-36. PubMed ID: 6728042
[TBL] [Abstract][Full Text] [Related]
28. Binding characteristics of [3H]ketanserin for serotonin-2 receptor in the rabbit platelet.
Tsuchihashi H; Yagi N; Kimura M; Shirota K; Kinami J; Nagatomo T
J Pharmacobiodyn; 1991 Aug; 14(8):461-6. PubMed ID: 1663547
[TBL] [Abstract][Full Text] [Related]
29. Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat.
Graham D; Tahraoui L; Langer SZ
Neuropharmacology; 1987 Aug; 26(8):1087-92. PubMed ID: 2958720
[TBL] [Abstract][Full Text] [Related]
30. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
[TBL] [Abstract][Full Text] [Related]
31. Detection of 5-hydroxytryptamine2 receptors by radioligand binding, northern blot analysis, and Ca2+ responses in rat primary astrocyte cultures.
Deecher DC; Wilcox BD; Dave V; Rossman PA; Kimelberg HK
J Neurosci Res; 1993 Jun; 35(3):246-56. PubMed ID: 8394435
[TBL] [Abstract][Full Text] [Related]
32. Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin.
Leysen JE; Gommeren W; De Clerck F
Eur J Pharmacol; 1983 Mar; 88(1):125-30. PubMed ID: 6852103
[TBL] [Abstract][Full Text] [Related]
33. 6-Hydroxydopamine pretreatment effects on alpha- and beta-adrenergic receptor adaptation to clorgyline.
Cohen RM; Aulakh C; McLellan C; Murphy DL
Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):158-61. PubMed ID: 2989714
[TBL] [Abstract][Full Text] [Related]
34. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.
Buckholtz NS; Zhou DF; Freedman DX; Potter WZ
Neuropsychopharmacology; 1990 Apr; 3(2):137-48. PubMed ID: 1969270
[TBL] [Abstract][Full Text] [Related]
35. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
Burris KD; Sanders-Bush E
Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
[TBL] [Abstract][Full Text] [Related]
36. Increased total activity in the rat after L-tryptophan plus the monoamine oxidase-A inhibitor amiflamine but not after L-tryptophan plus clorgyline.
Archer T; Fowler CJ; Fredriksson A; Lewander T; Magnusson O; Mohringe B; Söderberg U
Br J Pharmacol; 1985 Jul; 85(3):581-90. PubMed ID: 2411326
[TBL] [Abstract][Full Text] [Related]
37. LSD: effect on monoamine metabolites in rat prefrontal cortex.
Bowers MB; Salomonsson LA
Biochem Pharmacol; 1982 Dec; 31(24):4093-6. PubMed ID: 6186259
[No Abstract] [Full Text] [Related]
38. Clonazepam-induced up-regulation of serotonin1 and serotonin2 binding sites in rat frontal cortex.
Wagner HR; Reches A; Yablonskaya E; Fahn S
Adv Neurol; 1986; 43():645-51. PubMed ID: 2418653
[TBL] [Abstract][Full Text] [Related]
39. Characterization of serotonin binding sites on human platelets.
McBride PA; Mann JJ; McEwen B; Biegon A
Life Sci; 1983 Nov; 33(20):2033-41. PubMed ID: 6645789
[TBL] [Abstract][Full Text] [Related]
40. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
Norman AB; Battaglia G; Creese I
Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
